To the full analysis
ORIX stock: growth
IXORIX reported $22.12B in revenue for fiscal 2026, up 22.8% on the prior year, up 9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
6.4%
per year from 2007 to 2026, per share 6.6%
Earnings (Annual rate)
4.8%
per year from 2007 to 2026, per share 3.6%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 9.0% | 4.1% | 6.4% |
| Revenue per share | 11.3% | 5.7% | 6.6% |
| Earnings | 19.8% | 6.2% | 4.8% |
| Earnings per share | 22.3% | 7.9% | 3.6% |
| Free cash flow | −48.6% | no data | no data |
| Free cash flow per share | −47.6% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $6.84B | $1.23B | −$5.68B |
| 2008 | $6.91B | $1.05B | −$5.93B |
| 2009 | $5.94B | $137.29M | −$3.67B |
| 2010 | $5.2B | $236.43M | −$1.16B |
| 2011 | $5.3B | $413.41M | −$2.1B |
| 2012 | $4.92B | $522.92M | −$2.14B |
| 2013 | $6.59B | $699.71M | −$2.15B |
| 2014 | $8.6B | $1.17B | −$2.89B |
| 2015 | $13.61B | $1.47B | −$7.33B |
| 2016 | $14.83B | $1.63B | −$320.84M |
| 2017 | $16.77B | $1.71B | $2.06B |
| 2018 | $17.92B | $1.96B | $2.16B |
| 2019 | $15.19B | $2.03B | $2.69B |
| 2020 | $14.28B | $1.9B | $5.85B |
| 2021 | $14.36B | $1.2B | $6.51B |
| 2022 | $15.71B | $1.99B | $6.2B |
| 2023 | $16.68B | $1.82B | $4.87B |
| 2024 | $17.62B | $2.17B | $7.36B |
| 2025 | $18B | $2.2B | $7.53B |
| 2026 | $22.12B | $2.97B | $232.52M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 10 Nov 2026, previously Strong
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.